Great West Life Assurance CO Halozyme Therapeutics, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 145,745 shares of HALO stock, worth $6.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

145,745

Previous 143,802 1.35%

Holding current value

$6.97 Million

Previous $7.53 Million 10.79%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$51.3 - $64.42 $99,675 - $125,168	1,943 Added 1.35%	145,745 $8.35 Million
Q2 2024 Aug 12, 2024	BUY	$37.81 - $52.4 $489,488 - $678,370	12,946 Added 9.89%	143,802 $7.53 Million
Q1 2024 May 13, 2024	BUY	$33.68 - $41.95 $1.01 Million - $1.25 Million	29,845 Added 29.55%	130,856 $5.32 Million
Q4 2023 Feb 13, 2024	BUY	$33.32 - $42.1 $27,022 - $34,143	811 Added 0.81%	101,011 $3.72 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $163,596 - $197,562	4,487 Added 4.69%	100,200 $3.83 Million
Q2 2023 Aug 10, 2023	SELL	$30.28 - $38.74 $361,331 - $462,284	-11,933 Reduced 11.09%	95,713 $3.46 Million
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $74,822 - $126,828	-2,277 Reduced 2.07%	107,646 $4.11 Million
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $717,674 - $1.06 Million	17,915 Added 19.47%	109,923 $6.26 Million
Q3 2022 Nov 01, 2022	BUY	$38.53 - $51.78 $3.55 Million - $4.76 Million	92,008 New	92,008 $3.64 Million
Q2 2022 Aug 09, 2022	BUY	$37.35 - $48.3 $314,785 - $407,072	8,428 Added 11.08%	84,464 $3.72 Million
Q1 2022 May 12, 2022	BUY	$31.97 - $41.06 $183,156 - $235,232	5,729 Added 8.15%	76,036 $3.11 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $139,339 - $178,444	4,379 Added 6.64%	70,307 $2.83 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $546,927 - $659,953	14,217 Added 27.49%	65,928 $2.7 Million
Q2 2021 Aug 11, 2021	BUY	$38.84 - $51.31 $94,264 - $124,529	2,427 Added 4.92%	51,711 $2.35 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $163,492 - $212,900	-4,138 Reduced 7.75%	49,284 $2.05 Million
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $1.15 Million - $1.95 Million	44,685 Added 511.45%	53,422 $2.28 Million
Q3 2020 Nov 17, 2020	BUY	$25.74 - $29.63 $224,890 - $258,877	8,737 New	8,737 $229,000
Q3 2020 Nov 13, 2020	SELL	$25.74 - $29.63 $224,890 - $258,877	-8,737 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$16.25 - $26.81 $28,470 - $46,971	-1,752 Reduced 16.7%	8,737 $233,000
Q4 2019 Feb 11, 2020	BUY	$14.93 - $19.53 $156,600 - $204,850	10,489 New	10,489 $185,000
Q3 2019 Oct 25, 2019	SELL	$15.2 - $17.69 $232,529 - $270,621	-15,298 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$14.75 - $17.26 $36,358 - $42,545	-2,465 Reduced 13.88%	15,298 $0
Q1 2019 May 08, 2019	BUY	$13.94 - $17.58 $48,399 - $61,037	3,472 Added 24.3%	17,763 $285,000
Q3 2017 Nov 09, 2017	BUY	$11.76 - $17.4 $168,062 - $248,663	14,291	14,291 $248,000

Others Institutions Holding HALO

# of Institutions

544

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.66B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Halozyme Therapeutics, Inc. Transaction History